Click here to discover the largest collection of GeneMedi's Promise-ORF™ ORF/cDNA expression clones
Plasmid quantity:
- 10mg, 50mg, 100mg, 500mg, >1g
Talk to our Expert:
- • Research Grade
- • Endotoxin-Free Grade
- • High Quality (HQ) Grade
TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Human TNN/TN-W/TNW ORF/cDNA clone-Adenovirus plasmid (NM_022093.2)
Cat. No.: pGMAD000771
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human TNN/TN-W/TNW adenoviral expression plasmid for TNN adenovirus packaging, TNN adenovirus.
Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.
Datasheet
Go to
TNN/TN-W products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMAD000771 |
| Gene Name | TNN |
| Accession Number | NM_022093.2 |
| Gene ID | 63923 |
| Species | Human |
| Product Type | Adenovirus plasmid (overexpression) |
| Insert Length | 3900 bp |
| Gene Alias | TN-W,TNW |
| Fluorescent Reporter | EGFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Kanamycin |
| ORF Nucleotide Sequence | ATGAGTCTCCAGGAGATGTTCCGCTTCCCTATGGGGCTCCTGCTTGGCTCTGTGCTCCTGGTGGCTTCGGCCCCAGCCACTCTGGAGCCTCCCGGCTGCAGCAACAAGGAGCAACAGGTCACTGTCAGCCACACCTACAAGATCGATGTGCCCAAGTCTGCCTTGGTTCAGGTTGACGCTGACCCTCAGCCCCTCAGTGACGATGGGGCTTCGCTCTTGGCCCTGGGGGAGGCCAGGGAGGAACAGAACATCATCTTCAGGCACAACATCCGCCTTCAGACGCCACAGAAGGACTGCGAGTTGGCAGGCAGTGTCCAGGACCTCCTGGCCCGGGTGAAGAAGCTGGAGGAAGAGATGGTGGAGATGAAGGAACAGTGTAGTGCCCAGCGCTGCTGCCAGGGAGTCACTGATCTAAGCCGCCACTGCAGCGGCCACGGGACCTTCTCCCTGGAGACCTGCAGCTGCCACTGCGAAGAGGGCAGGGAGGGCCCCGCCTGCGAGCGGCTGGCCTGCCCCGGGGCGTGCAGCGGCCACGGGCGTTGCGTGGACGGGCGCTGCCTGTGCCATGAGCCCTACGTGGGTGCCGACTGCGGCTACCCGGCCTGCCCTGAGAACTGCAGCGGACACGGCGAGTGCGTGCGCGGCGTGTGCCAGTGCCACGAAGACTTCATGTCGGAGGACTGCAGCGAGAAGCGCTGTCCCGGCGACTGCAGCGGCCACGGCTTCTGTGACACGGGCGAGTGCTACTGCGAGGAGGGCTTCACAGGCCTGGACTGTGCCCAGGTGGTCACCCCACAGGGCCTGCAGCTGCTCAAGAACACGGAGGATTCTCTGCTGGTGAGCTGGGAGCCCTCCAGCCAGGTGGATCACTACCTCCTCAGCTACTACCCCCTGGGGAAGGAGCTCTCTGGGAAGCAGATCCAAGTGCCCAAGGAGCAGCACAGCTATGAGATTCTTGGTTTGCTGCCTGGAACCAAGTACATAGTCACCCTGCGTAACGTCAAGAATGAAGTTTCTAGCAGCCCACAGCATCTACTTGCCACCACAGACCTTGCTGTGCTTGGCACTGCCTGGGTGACAGATGAGACTGAGAACTCCCTTGACGTGGAGTGGGAAAACCCCTCAACTGAGGTGGACTACTACAAGCTGCGATATGGCCCCATGACAGGACAGGAGGTAGCTGAGGTCACTGTGCCCAAGAGCAGTGACCCCAAGAGCCGATATGACATCACTGGTCTGCACCCGGGGACTGAGTATAAGATCACGGTGGTGCCCATGAGAGGAGAGCTGGAGGGCAAGCCGATCCTCCTGAATGGCAGGACAGAAATTGACAGTCCAACCAATGTTGTCACTGATCGAGTGACTGAAGACACAGCAACTGTCTCCTGGGACCCAGTGCAGGCTGTCATAGACAAGTATGTAGTGCGCTACACTTCTGCTGATGGGGACACCAAGGAAATGGCAGTGCACAAGGATGAGAGCAGCACTGTCCTGACGGGCCTGAAGCCAGGAGAGGCATACAAGGTCTACGTGTGGGCTGAAAGGGGCAACCAGGGGAGCAAGAAAGCTGACACCAATGCCCTCACAGAAATTGACAGCCCAGCAAACCTGGTGACTGACCGGGTGACTGAGAATACCGCCACCATCTCCTGGGACCCGGTACAGGCCACCATTGACAAGTACGTGGTGCGCTACACCTCTGCTGACGACCAAGAGACCAGAGAGGTTCTGGTGGGGAAGGAGCAGAGCAGCACTGTCCTGACAGGCCTGAGGCCAGGTGTGGAGTACACAGTGCATGTCTGGGCCCAGAAGGGGGACCGAGAGAGCAAGAAGGCTGACACCAACGCCCCGACAGATATTGACAGCCCCAAAAACCTGGTGACTGACCGGGTGACAGAGAATATGGCCACGGTCTCCTGGGACCCGGTGCAGGCCGCCATTGACAAGTACGTGGTGCGCTACACCTCTGCTGGTGGAGAGACCAGGGAGGTTCCGGTGGGGAAGGAGCAGAGCAGCACAGTCCTGACAGGCCTGAGACCGGGTATGGAGTACATGGTGCACGTGTGGGCCCAGAAGGGGGACCAGGAGAGCAAGAAGGCCGACACCAAGGCCCAGACAGACATTGACAGCCCCCAAAACCTGGTGACCGACCGGGTGACAGAGAATATGGCCACTGTCTCCTGGGACCCGGTGCGGGCCACCATTGACAGGTATGTGGTGCGCTACACCTCTGCCAAGGACGGAGAGACCAGGGAGGTTCCGGTGGGGAAGGAGCAGAGTAGCACTGTCCTGACGGGCCTGAGGCCGGGTGTGGAGTACACGGTGCACGTGTGGGCCCAGAAGGGGGCCCAGGAGAGCAAGAAGGCTGACACCAAGGCCCAGACAGACATTGACAGCCCCCAAAACCTGGTCACTGACTGGGTGACAGAGAATACAGCCACTGTCTCCTGGGACCCGGTGCAGGCCACCATTGACAGGTATGTGGTGCACTACACGTCTGCCAACGGAGAGACCAGGGAGGTTCCAGTGGGGAAGGAGCAGAGCAGCACTGTCCTGACGGGCCTGAGGCCGGGCATGGAGTACACGGTGCACGTGTGGGCCCAGAAGGGGAACCAGGAGAGCAAGAAGGCTGACACCAAGGCCCAGACAGAAATTGACGGCCCCAAAAACCTAGTGACTGACTGGGTGACGGAGAATATGGCCACTGTCTCCTGGGACCCGGTTCAGGCCACCATTGACAAGTACATGGTGCGCTACACCTCTGCTGACGGAGAGACCAGGGAGGTTCCGGTGGGGAAGGAGCACAGCAGCACTGTCCTGACGGGCCTGAGACCAGGCATGGAGTACATGGTGCACGTGTGGGCCCAGAAGGGGGCCCAGGAGAGCAAGAAGGCTGACACCAAGGCCCAGACAGAACTCGACCCTCCCAGAAACCTTCGTCCATCTGCTGTAACGCAGTCTGGTGGCATATTGACCTGGACGCCCCCCTCTGCTCAGATCCACGGCTACATTCTGACTTACCAGTTCCCAGATGGCACAGTTAAGGAGATGCAGCTGGGACGGGAAGACCAGAGGTTTGCGTTGCAAGGCCTTGAGCAAGGCGCCACCTACCCTGTCTCCCTTGTTGCCTTTAAGGGTGGTCGCCGGAGCAGAAATGTATCCACCACCCTCTCCACAGTTGGTGCCCGTTTCCCACACCCTTCGGACTGCAGTCAGGTTCAGCAGAACAGCAATGCCGCCAGTGGTCTGTACACCATCTACCTGCATGGCGATGCCAGCCGGCCCCTGCAGGTGTACTGTGACATGGAAACGGACGGAGGTGGCTGGATTGTCTTCCAGAGGCGGAACACTGGGCAGCTGGATTTCTTCAAGCGATGGAGGAGCTATGTGGAAGGCTTTGGGGACCCCATGAAGGAGTTCTGGCTTGGACTTGACAAGCTACACAACCTCACCACCGGCACTCCAGCGCGGTATGAGGTGAGAGTGGATTTACAGACTGCCAATGAATCTGCCTATGCTATATATGATTTCTTCCAAGTGGCCTCCAGCAAGGAGCGGTATAAGCTGACAGTTGGGAAATACAGAGGCACGGCAGGGGATGCTCTTACTTACCACAATGGATGGAAGTTTACAACTTTTGACAGAGACAATGATATCGCACTCAGCAACTGTGCCCTGACACATCATGGTGGCTGGTGGTATAAGAACTGCCACTTGGCCAACCCTAATGGCAGATATGGGGAGACCAAGCACAGTGAGGGGGTGAACTGGGAGCCTTGGAAAGGACATGAATTCTCCATTCCTTACGTGGAGTTGAAAATCCGCCCTCATGGCTACAGCAGGGAGCCTGTCCTGGGCAGAAAGAAGCGGACGCTGAGAGGAAGGCTGCGAACGTTCTGA |
| ORF Protein Sequence | MSLQEMFRFPMGLLLGSVLLVASAPATLEPPGCSNKEQQVTVSHTYKIDVPKSALVQVDADPQPLSDDGASLLALGEAREEQNIIFRHNIRLQTPQKDCELAGSVQDLLARVKKLEEEMVEMKEQCSAQRCCQGVTDLSRHCSGHGTFSLETCSCHCEEGREGPACERLACPGACSGHGRCVDGRCLCHEPYVGADCGYPACPENCSGHGECVRGVCQCHEDFMSEDCSEKRCPGDCSGHGFCDTGECYCEEGFTGLDCAQVVTPQGLQLLKNTEDSLLVSWEPSSQVDHYLLSYYPLGKELSGKQIQVPKEQHSYEILGLLPGTKYIVTLRNVKNEVSSSPQHLLATTDLAVLGTAWVTDETENSLDVEWENPSTEVDYYKLRYGPMTGQEVAEVTVPKSSDPKSRYDITGLHPGTEYKITVVPMRGELEGKPILLNGRTEIDSPTNVVTDRVTEDTATVSWDPVQAVIDKYVVRYTSADGDTKEMAVHKDESSTVLTGLKPGEAYKVYVWAERGNQGSKKADTNALTEIDSPANLVTDRVTENTATISWDPVQATIDKYVVRYTSADDQETREVLVGKEQSSTVLTGLRPGVEYTVHVWAQKGDRESKKADTNAPTDIDSPKNLVTDRVTENMATVSWDPVQAAIDKYVVRYTSAGGETREVPVGKEQSSTVLTGLRPGMEYMVHVWAQKGDQESKKADTKAQTDIDSPQNLVTDRVTENMATVSWDPVRATIDRYVVRYTSAKDGETREVPVGKEQSSTVLTGLRPGVEYTVHVWAQKGAQESKKADTKAQTDIDSPQNLVTDWVTENTATVSWDPVQATIDRYVVHYTSANGETREVPVGKEQSSTVLTGLRPGMEYTVHVWAQKGNQESKKADTKAQTEIDGPKNLVTDWVTENMATVSWDPVQATIDKYMVRYTSADGETREVPVGKEHSSTVLTGLRPGMEYMVHVWAQKGAQESKKADTKAQTELDPPRNLRPSAVTQSGGILTWTPPSAQIHGYILTYQFPDGTVKEMQLGREDQRFALQGLEQGATYPVSLVAFKGGRRSRNVSTTLSTVGARFPHPSDCSQVQQNSNAASGLYTIYLHGDASRPLQVYCDMETDGGGWIVFQRRNTGQLDFFKRWRSYVEGFGDPMKEFWLGLDKLHNLTTGTPARYEVRVDLQTANESAYAIYDFFQVASSKERYKLTVGKYRGTAGDALTYHNGWKFTTFDRDNDIALSNCALTHHGGWWYKNCHLANPNGRYGETKHSEGVNWEPWKGHEFSIPYVELKIRPHGYSREPVLGRKKRTLRGRLRTF |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-SE1345-Ab | Anti-TENN/ TNN/ TN-W functional antibody |
| Target Antigen | GM-Tg-g-SE1345-Ag | TNN protein |
| ORF Viral Vector | pGMAD000771 | Human TNN Adenovirus plasmid |
| ORF Viral Vector | vGMAD000771 | Human TNN Adenovirus particle |
Target information
| Target ID | GM-SE1345 |
| Target Name | TNN |
| Gene ID | 63923, 329278, 708587, 304913, 101097863, 490335, 517433, 100061556 |
| Gene Symbol and Synonyms | tenascin-W,TN-W,TNN,TNW |
| Uniprot Accession | Q9UQP3 |
| Uniprot Entry Name | TENN_HUMAN |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Not Available |
| Disease | Not Available |
| Gene Ensembl | ENSG00000120332 |
| Target Classification | Not Available |
Predicted to enable integrin binding activity. Predicted to be involved in several processes, including generation of neurons; negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation; and negative regulation of osteoblast differentiation. Predicted to act upstream of or within axonogenesis. Predicted to be located in extracellular matrix and neuron projection. Predicted to be active in collagen-containing extracellular matrix and extracellular space. [provided by Alliance of Genome Resources, Apr 2022]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.
Facebook
LinkedIn
Twitter
